Home
Noxopharm Limited
ASX Code
NOX
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.noxopharm.com/site/investors/share-price
Website
https://www.noxopharm.com/site/content/
About
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.
News
Noxopharm (ASX: NOX) - Webinar Presentation |
Noxopharm Study Finds its Drug Improves Prostate Cancer Survival Rates |
Noxopharm (ASX:NOX) - Hidden Gems Webinar Presentation |